Metabolomic Approaches for Detection and Identification of Biomarkers and Altered Pathways in Bladder Cancer
Nicola Antonio di Meo(University of Bari Aldo Moro), Giuseppe Lucarelli(University of Bari Aldo Moro), Davide Loizzo(University of Bari Aldo Moro), Leonardo Vincenti, Octavian Sabin Tătaru(Universitatea de Medicină, Farmacie, Științe și Tehnologie „George Emil Palade” din Târgu Mureș), Cinzia Bizzoca, Camillo Porta(University of Pavia), Matteo Ferro(European Institute of Oncology), Michele Battaglia(University of Bari Aldo Moro), Pasquale Ditonno(University of Bari Aldo Moro), Felice Crocetto(University of Naples Federico II), Alessandro Stella(University of Bari Aldo Moro), Riccardo Autorino(Cleveland Clinic), Monica Rutigliano(University of Bari Aldo Moro), Savio Domenico Pandolfo(University of L'Aquila)
Cited by 61
Related Papers
Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma: Subanalyses of a phase III trial
|Journal of Hepatology|2012|821
Tivantinib for second-line treatment of advanced hepatocellular carcinoma: a randomised, placebo-controlled phase 2 study
|The Lancet Oncology|2012|550
Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
|Annals of Oncology|2012|275